ECS Botanics Holdings Ltd
ASX:ECS
ECS Botanics Holdings Ltd
ASX:ECS
Price:
0.005
AUD
Market Closed
Market Cap:
AU$8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ECS Botanics Holdings Ltd
ASX:ECS
|
AU |
|
I
|
Iberdrola SA
XHAM:IBE1
|
ES |
|
Ramco Cements Limited
NSE:RAMCOCEM
|
IN |
|
Zhongtai Securities Co Ltd
SSE:600918
|
CN |
|
R
|
Richmond Mutual Bancorporation Inc
NASDAQ:RMBI
|
US |
|
CIMIC Group Ltd
ASX:CIM
|
AU |
|
Cheer Holding Inc
NASDAQ:CHR
|
CN |
|
P
|
Pearson PLC
XBER:PES
|
UK |
|
J
|
JDC Corp
TSE:1887
|
JP |
|
H
|
H S India Ltd
BSE:532145
|
IN |
|
Akcansa Cimento Sanayi ve Ticaret AS
IST:AKCNS.E
|
TR |
|
Antibe Therapeutics Inc
TSX:ATE
|
CA |
|
F
|
Fade Gida Yatirim Sanayi Ticaret AS
IST:FADE.E
|
TR |
|
DocuSign Inc
NASDAQ:DOCU
|
US |
|
H
|
Hutchison Telecommunications (Australia) Ltd
ASX:HTA
|
AU |
|
S
|
San Miguel Corp
XPHS:SMC
|
PH |
|
C
|
Cathay Consolidated Inc
TWSE:1342
|
TW |
|
B
|
Bellavista Resources Ltd
ASX:BVR
|
AU |
|
Braemar Shipping Services PLC
LSE:BMS
|
UK |
|
R
|
Reelcause Inc
OTC:RCIT
|
US |
|
Seker Finansal Kiralama AS
IST:SEKFK.E
|
TR |
|
Westlake Chemical Partners LP
NYSE:WLKP
|
US |
|
Fudo Tetra Corp
TSE:1813
|
JP |
Multiples-Based Value
The Multiples-Based Value of one
ECS
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.005 AUD,
ECS Botanics Holdings Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ECS Multiples-Based Value
LOCKED
Multiples Across Competitors
ECS Competitors Multiples
ECS Botanics Holdings Ltd Competitors
ECS Botanics Holdings Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
ECS Botanics Holdings Ltd
ASX:ECS
|
8m AUD | 0.4 | -1.7 | -5.3 | -5.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
